PharmiWeb.com - Global Pharma News & Resources
PharmiWeb Today Story
Parkinson’s Foundation grants £200,000 to Parkinson’s UK to invest in the Parkinson’s Virtual Biotech

LONDON12 November, 2019 – Charity Parkinson’s UK today announced an international partnership with US-based organisation, The Parkinson’s Foundation who have granted £200,000 towards a potential new therapy for people with Parkinson’s as part of the Parkinson’s Virtual Biotech, led by the charity.

Each year, Parkinson’s UK, their supporters and partners invest more than £4 million into the Parkinson’s Virtual Biotech to rapidly develop and test the most promising research findings with the aim of turning them into treatments that will transform the lives of people with Parkinson's. The Parkinson’s Virtual Biotech focuses on the projects that matter the most to the Parkinson’s community and is powered by collaborations with world-leading research organisations that are best placed to deliver on the aims of each project. 

The Parkinson’s Foundation grant will help support a project seeking to discover new ways that may prevent brain cell death by stabilising the source of energy essential to cell survival, the mitochondria. This is the first international funding received by Parkinson’s UK for the Parkinson’s Virtual Biotech and signals the start of a joint trans-Atlantic mission to fast-track the best scientific ideas towards groundbreaking new treatments for Parkinson’s.

"We are delighted to receive this investment from the Parkinson's Foundation to support a growing portfolio of projects in the Parkinson’s Virtual Biotech,” said Steve Ford, Chief Executive at Parkinson’s UK. “While we have made huge strides in our research efforts, we have long recognised that we c…

Read More...
Parkinson’s Foundation grants £200,000 to Parkinson’s UK to invest in the Parkinson’s Virtual Biotech

Articles